Cargando…
Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
BACKGROUND: Hypermethylated in Cancer 1 (HIC1) was originally confirmed as a tumor suppressor and has been found to be hypermethylated in human cancers. Although growing evidence has supported the critical roles of HIC1 in cancer initiation and development, its roles in tumor immune microenvironment...
Autores principales: | Wu, Yanlin, Lin, Zhengjun, Tang, Xianzhe, Tong, Zhongyi, Ji, Yuqiao, Xu, Yingting, Zhou, Ziting, Yang, Jing, Li, Zhihong, Liu, Tang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300279/ https://www.ncbi.nlm.nih.gov/pubmed/37388742 http://dx.doi.org/10.3389/fimmu.2023.1182030 |
Ejemplares similares
-
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023) -
Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022) -
Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021) -
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
por: Guo, Liang, et al.
Publicado: (2020) -
Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Song, Jing, et al.
Publicado: (2021)